Chi-Wei Wang

Asia University

Papers

1

Total Citations

13

H-Index

1

About

Dr. Chi-Wei Wang is a leading cardiovascular surgeon whose research focuses on advancing minimally invasive surgical techniques for coronary artery disease. His work centers on comparing the clinical efficacy of robot-assisted coronary artery bypass grafting (R-CABG) against conventional sternotomy approaches, with particular emphasis on outcomes for patients with multivessel coronary artery disease (MVD). Dr. Wang’s most cited study, published in 2021 with 13 citations, provides real-world evidence demonstrating that R-CABG offers comparable safety and efficacy to traditional open-heart surgery while potentially reducing recovery times and surgical trauma. This contribution is pivotal in validating robotic platforms as a viable alternative to the gold standard conventional CABG, bridging the gap between percutaneous coronary intervention and traditional bypass surgery. By systematically analyzing perioperative outcomes, graft patency, and long-term survival, Dr. Wang has helped establish evidence-based guidelines for patient selection in robotic cardiac surgery. His work continues to shape the evolution of cardiothoracic surgery, offering patients less invasive options without compromising clinical results. For researchers and clinicians, Dr. Wang’s findings underscore the transformative potential of robotics in complex coronary revascularization.

Research Focus

Key Achievements

1
H-Index
1
Papers
13
Total Citations
13
Avg Citations/Paper
🏆 Most Cited Paper
Clinical outcomes of multivessel coronary artery disease patients revascularized by robot-assisted vs conventional standard coronary artery bypass graft surgeries in real-world practice
13 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: Asia University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago